ARISTO vs ARVEE: Stock Comparison

ARISTO vs ARVEE LABORATORIES IUpdated 22 Sept 26, 4:08 PM ISTNSE & company filings

ARVEE LABORATORIES I is the larger company by market capitalisation. ARISTO shows a higher ROE and a higher ROCE, while ARVEE LABORATORIES I shows faster revenue growth, lower leverage and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

ARISTO leads 3; ARVEE leads 7 of 11

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

ARISTOARVEE

Valuation lens

What price are you paying?

Market CapContext only
₹76 Cr
₹256 Cr
P/E RatioSame reading
69.87x
P/B RatioSame reading
5.22x
EPSARISTO has the higher reading
₹10.55
₹3.67
Book ValueContext only
₹65.39
₹30.53
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
ARVEE is the larger company
₹256 Cr vs ₹76 Cr
EPS
ARISTO has higher earnings per share
₹10.55 vs ₹3.67
Revenue Growth (TTM YoY)
ARVEE has faster revenue growth
67.5% vs 0%
EPS Growth (TTM YoY)
ARVEE has faster EPS growth
684.4% vs 0%
Qtr Sales Growth
ARVEE has stronger quarterly sales growth
59.43% vs 41.83%
Qtr Profit Growth
ARVEE has stronger quarterly profit growth
225.68% vs 72.26%
ROE
ARISTO has a higher ROE
16.14% vs 7.48%
ROCE
ARISTO has a higher ROCE
13.02% vs 7.73%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricARISTOARVEE
SectorChemicals
IndustrySpecialty Chemicals

Price

MetricARISTOARVEE
Live Price₹236.07
Day Change13.02%
Volume2.3 L
52-Week High₹290.78
52-Week Low₹129.11
Distance from 52W High-18.81%

Valuation

MetricARISTOARVEE
Market Cap₹76 Cr₹256 Cr
P/E Ratio69.87x
P/B Ratio5.22x
EPS₹10.55₹3.67
Book Value₹65.39₹30.53
Dividend Yield0%0%

Growth

MetricARISTOARVEE
Revenue Growth (TTM YoY)0%67.5%
EPS Growth (TTM YoY)0%684.4%
Qtr Sales Growth41.83%59.43%
Qtr Profit Growth72.26%225.68%

Profitability & Leverage

MetricARISTOARVEE
ROE16.14%7.48%
ROCE13.02%7.73%
Net Margin0%7.65%
Operating Margin3.73%8.46%
Debt to Equity0.8x0.03x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricARISTOARVEE
Promoter Holding73.42%73.5%
FII Holding0%0%
DII Holding0%0%
Public Holding26.58%26.5%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ARISTO and ARVEE LABORATORIES I.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.